Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 12 Aug 2025 for Turnstone Biologics Corp.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
No signal scores available.
Versant Ventures V, LLC: trading record in brief
This profile gathers the share dealings of Versant Ventures V, LLC across 2 companies, led by Repare Therapeutics Inc. and Turnstone Biologics Corp. Between 5 May 2021 and 8 August 2025, the trades on record add up to 6 filings.
No open-market purchase appears, only 1 sale worth €2.8M.
On 12 August 2025 came the latest disclosure, a transaction in Turnstone Biologics Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Versant Ventures V, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
2,726,322 sharesCommon StockSEC:0000950170-25-107403:0
2,528,864 sharesCommon StockSEC:0001209191-23-043527:0
▼
Same trade as the filing by Versant Vantage I, L.P., counted once · View ↗
250,000 shares@ US$12.2517100.0% of flowCommon SharesSEC:0000899243-22-021348:0
152,071 shares0Common SharesSEC:0000899243-21-032177:0
75,000 shares0Common SharesSEC:0000899243-21-021798:0
211,277 shares0Common SharesSEC:0000899243-21-018685:0
6 of 5 declarations
